copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Drugs (psychoactive) - World Health Organization (WHO) The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important
WHO Drug Information About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours
Nepal strengthens lymphatic filariasis elimination efforts through . . . To accelerate the elimination of lymphatic filariasis (LF) as a public health problem by 2030, Nepal launched a Mass Drug Administration (MDA) campaign in high-burden areas of Banke district, Lumbini Province With technical and financial support from WHO Nepal, the campaign was carried out in four municipalities of Banke from February to May 2025 It successfully reached over 70% of the
WHO updates list of drug-resistant bacteria most threatening to human . . . The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritization
Active TB drug-safety monitoring and management (aDSM) Health programmes that systematically monitor patient safety are in a better position to prevent and manage adverse drug reactions (ADRs), relieve patient suffering and improve treatment outcomes Likewise, TB programmes that actively pursue drug-safety monitoring and management are better prepared to introduce new anti-TB drugs and novel regimens
New treatment for drug-resistant tuberculosis New treatment for drug-resistant tuberculosis Effective treatment of tuberculosis (TB), including its drug-resistant forms, relies on the use of several medicines administered in combination for an adequate duration
ECP PR - World Health Organization (WHO) For finished drug products, the sampling procedure should take ac-count of the official and non-official tests required for the individual dosage form (e g tablets or parenteral preparations) Non-official tests could include testing for adulteration and counterfeiting